Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Govoni

Showing results (161-170 of 254) with videos related to

Pageof 26
Sort By:
Annals of the Rheumatic Diseases|March 19, 2013
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre studyLuca Quartuccio, Martina Fabris, Elena Pontarini, et al.
The Journal of Rheumatology|March 17, 2019
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE StudyPierluigi Macchioni, Carlo Salvarani, Niccolò Possemato, et al.
Arthritis and Rheumatism|September 25, 2012
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockersMartina Fabris, Luca Quartuccio, Ed Vital, et al.
Clinical and Experimental Rheumatology|May 4, 2023
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based studyFausto Salaffi, Marco Di Carlo, Manuela Di Franco, et al.
Clinical and Experimental Rheumatology|October 6, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for RheumatologyAndreina Manfredi, Giulia Cassone, Raffaella Izzo, et al.
Annals of the Rheumatic Diseases|March 31, 2019
2019 update of the EULAR recommendations for the management of systemic lupus erythematosusAntonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Clinical Rheumatology|May 22, 2016
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patientsPaolo Sfriso, Roberta Priori, Guido Valesini, et al.
Pageof 26

Showing results (161-170 of 254) with videos related to

Sort By:
Pageof 26
Annals of the Rheumatic Diseases|March 19, 2013
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre studyLuca Quartuccio, Martina Fabris, Elena Pontarini, et al.
The Journal of Rheumatology|March 17, 2019
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE StudyPierluigi Macchioni, Carlo Salvarani, Niccolò Possemato, et al.
Arthritis and Rheumatism|September 25, 2012
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockersMartina Fabris, Luca Quartuccio, Ed Vital, et al.
Clinical and Experimental Rheumatology|May 4, 2023
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based studyFausto Salaffi, Marco Di Carlo, Manuela Di Franco, et al.
Clinical and Experimental Rheumatology|October 6, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for RheumatologyAndreina Manfredi, Giulia Cassone, Raffaella Izzo, et al.
Annals of the Rheumatic Diseases|March 31, 2019
2019 update of the EULAR recommendations for the management of systemic lupus erythematosusAntonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
Clinical Rheumatology|May 22, 2016
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patientsPaolo Sfriso, Roberta Priori, Guido Valesini, et al.
Pageof 26